Xiaojia Song

1.5k total citations
19 papers, 967 citations indexed

About

Xiaojia Song is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Xiaojia Song has authored 19 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Xiaojia Song's work include RNA modifications and cancer (6 papers), Cancer-related gene regulation (6 papers) and Epigenetics and DNA Methylation (3 papers). Xiaojia Song is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related gene regulation (6 papers) and Epigenetics and DNA Methylation (3 papers). Xiaojia Song collaborates with scholars based in China, Sweden and United States. Xiaojia Song's co-authors include Lifen Gao, Xiaohong Liang, Chunhong Ma, Hualin Zhang, Tixiao Wang, Wenjiang Yan, Xiao Liu, Chunyang Li, Zehua Wang and Zhuanchang Wu and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Cancer Research.

In The Last Decade

Xiaojia Song

19 papers receiving 956 citations

Peers

Xiaojia Song

IMMUN

ONCOL

EPIDE

Tixiao Wang China

Xu Cao China

Pingping Dong China

Chengyu Shi China

Xiaowen Huang China

Arianna Marino Italy

Shinji Furuya Japan

Jihua Shi China

Ryo Kamata Japan

Tixiao Wang China

Xiaojia Song

290 ×0.7

257 ×0.6

IMMUN

120 ×0.5

ONCOL

128 ×0.7

123 ×0.8

EPIDE

Citations per year, relative to Xiaojia Song Xiaojia Song (= 1×) peers Tixiao Wang

Countries citing papers authored by Xiaojia Song

Since Specialization

Citations

This map shows the geographic impact of Xiaojia Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojia Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojia Song more than expected).

Fields of papers citing papers by Xiaojia Song

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojia Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojia Song. The network helps show where Xiaojia Song may publish in the future.

Co-authorship network of co-authors of Xiaojia Song

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojia Song. A scholar is included among the top collaborators of Xiaojia Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojia Song. Xiaojia Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Fan, Yu‐Chen, Zehua Wang, Mengzhen Li, et al.. (2024). Probiotics and their metabolite spermidine enhance IFN-γ+CD4+ T cell immunity to inhibit hepatitis B virus. Cell Reports Medicine. 5(11). 101822–101822. 5 indexed citations

Song, Xiaojia, Yajie Yu, Haiying Zhou, et al.. (2024). Acute Macular Neuroretinopathy Associated with COVID-19 Pandemic: A Real-world Observation Study. Asia-Pacific Journal of Ophthalmology. 13(5). 100103–100103. 1 indexed citations

Zhang, Yankun, Yu‐Chen Fan, Xiaohui Zhang, et al.. (2023). ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury. Nature Communications. 14(1). 7527–7527. 10 indexed citations

Sun, Yang, Yan Teng, Liyuan Wang, et al.. (2022). LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1. Advanced Science. 9(16). e2103135–e2103135. 32 indexed citations

Song, Xiaojia, Na Li, Yuan Liu, et al.. (2021). CD169-positive macrophages enhance abscopal effect of radiofrequency ablation therapy in liver cancer. Translational Oncology. 15(1). 101306–101306. 13 indexed citations

Wang, Liyuan, Yang Sun, Xiaojia Song, et al.. (2021). Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes. Cellular and Molecular Immunology. 18(8). 1871–1882. 35 indexed citations

Lin, Qinghai, Zhuanchang Wu, Xuetian Yue, et al.. (2020). ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. EBioMedicine. 53. 102676–102676. 49 indexed citations

Wang, Zehua, Liang Kong, Siyu Tan, et al.. (2020). Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3. The Journal of Immunology. 204(8). 2232–2241. 47 indexed citations

Song, Xiaojia, et al.. (2020). Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma. Hepatoma Research. 2020. 3 indexed citations

10.

Lin, Qinghai, Zhuanchang Wu, Yankun Zhang, et al.. (2020). ZHX2 inhibits SREBP1c‐mediated de novo lipogenesis in hepatocellular carcinoma via miR‐24‐3p. The Journal of Pathology. 252(4). 358–370. 35 indexed citations

11.

Yang, Huimin, Tingting Xie, Xianhong Du, et al.. (2019). Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Molecular Metabolism. 23. 24–36. 146 indexed citations

12.

Wu, Zhuanchang, Liyuan Wang, Xiaojia Song, et al.. (2019). Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake. Cell Death and Differentiation. 27(5). 1693–1708. 47 indexed citations

13.

Tan, Siyu, Yong Xu, Zehua Wang, et al.. (2019). Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling. Cancer Research. 80(5). 1130–1142. 117 indexed citations

14.

Xu, Leiqi, Zhuanchang Wu, Zehua Wang, et al.. (2018). Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners. Antiviral Research. 153. 114–123. 24 indexed citations

15.

Xu, Yong, Zehua Wang, Xianhong Du, et al.. (2018). Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication. Journal of Cellular and Molecular Medicine. 22(6). 3192–3201. 16 indexed citations

16.

Song, Xiaojia, Siyu Tan, Zhuanchang Wu, et al.. (2018). HBV suppresses ZHX2 expression to promote proliferation of HCC through miR‐155 activation. International Journal of Cancer. 143(12). 3120–3130. 56 indexed citations

17.

Liu, Yuan, Yong Xu, Bo Wang, et al.. (2016). Hepatitis B virus X protein amplifies TGF-β promotion on HCC motility through down-regulating PPM1a. Oncotarget. 7(22). 33125–33135. 31 indexed citations

18.

Yan, Wenjiang, Xiao Liu, Hualin Zhang, et al.. (2015). Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages. Gut. 64(10). 1593–1604. 261 indexed citations

19.

Qin, Shengxue, et al.. (2015). The effect of fruit and vegetable intake on the development of lung cancer: a meta-analysis of 32 publications and 20 414 cases. European Journal of Clinical Nutrition. 69(11). 1184–1192. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact